RECALL ALERT: Wells Pharmacy Network Recalls Multiple Veterinary Medications Due to Sterility Concerns

Wells Pharmacy Network (“WPN”) is voluntarily recalling all sterile human and veterinary products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry (list below) due to the Food and Drug Administration’s (“FDA”) concern over a lack of sterility assurance.

Administration of a drug product intended to be sterile that has microbial contamination may result in infections that may be serious and life-threatening.

The recalled products were used for a variety of indications. NO VIAL OR PORTION OF ANY LOT OF THESE MEDICATIONS HAS BEEN FOUND TO BE NON STERILE. All recalled products have a label that includes the name Wells Pharmacy Network, logo, drug name, and expiration date. If unsure, Customers can call the pharmacy to determine if their product is on the list.  To date, no adverse events have been reported.

WPN takes the utmost care to ensure patient safety. All patients and providers that received any sterile compounded products prepared between February 22, 2016 and September 14, 2016, and that remain within expiry, should take the following actions:

• Discontinue use of the products;
• Quarantine any unused product until further instructions are received on how to return the product; and
• Contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday, between 9:00 am and 6:00 pm EST or email at [email protected] to discuss the return of any unused sterile product.

Customers with questions regarding this recall can contact WPN at the Quality hotline at (800) 794-2360 Monday through Friday between 9:00 am and 6:00 pm EST or email at [email protected]. Customers should contact their physician, healthcare provider, or veterinarian if they have experienced any problems that may be related to using these products. Providers who have dispensed any sterile products prepared between February 22, 2016 and September 14, 2016 to a patient(s) for use outside of the provider’s office should contact the patient(s) to whom product was dispensed and advise the patient(s) of this recall.

Adverse reactions or quality problems experienced with the use of these products in animals may be reported to FDA in the following ways:

• For reporting animal adverse drug events, please follow the link to the FORM FDA 1932a found at: www.fda.gov/AnimalVeterinary/SafetyHealth/ReportaProblem/ucm055305.htm

This recall is being conducted with the knowledge of and in cooperation with the FDA.

Wells Pharmacy Network specializes in “wellness, anti-aging, weight management, urology, ophthalmology, and veterinary compounding solutions.”

List of VETERINARY products to be recalled:

Drug	Lot #

HISTRELIN ACETATE, LYOPHILIZED 5.5MG INJECTABLE

04062016@6

PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE

04082016@7

DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE

04272016@94

MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE

05022016@11

ESTRADIOL CYPIONATE 5MG/ML INJECTABLE

05092016@12

GLUCOSAMINE SULFATE 20% INJECTABLE

05102016@6

PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE

05112016@3

PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE

05112016@8

METHOCARBAMOL 100MG/ML INJECTABLE

05272016@3

MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE

05272016@5

PENTOSAN SODIUM POLYSULFATE 250MG/ML INJECTABLE

06142016@47

PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE

06152016@1

MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE

06202016@2

METHOCARBAMOL 100MG/ML INJECTABLE

06222016@7

MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE

06232016@27

ESTRONE AQUEOUS 5MG/ML INJECTABLE

06272016@29

ESTRADIOL CYPIONATE 5MG/ML INJECTABLE

06282016@79

ESTRONE AQUEOUS 5MG/ML INJECTABLE

06292016@5

PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE

07072016@7

CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC

07142016@35

PHENYLEPHRINE HCL – (5ML) 1MG/ML (0.1%) INJECTABLE

07202016@44

ESTRADIOL CYPIONATE 5MG/ML INJECTABLE

08022016@13

CYCLOSPORINE (A) OIL SOLUTION – (10ML) 2% OPHTHALMIC

08022016@20

PROGESTERONE IN SESAME OIL 150MG/ML INJECTABLE

08022016@27

DETOMIDINE HCL/XYLAZINE (20ML) 10MG/10MG/ML INJECTABLE

08022016@70

ESTRONE AQUEOUS 5MG/ML INJECTABLE

08022016@8

FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE

08052016@47

FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE

08092016@57

FLUNIXIN MEGLUMINE 50MG/ML INJECTABLE

08112016@7

ESTRONE AQUEOUS 5MG/ML INJECTABLE

08182016@7

MEDROXYPROGESTERONE ACETATE 200MG/ML INJECTABLE

08222016@18

For a complete list, including human medications involved in this recall, click here.